Rajesh Shrotriya - Jun 15, 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc. (CASI)

Role
Director
Signature
/s/ Cynthia W. Hu, attorney-in-fact for Rajesh C. Shrotriya
Stock symbol
CASI
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/16/2021, 04:02 PM
Previous filing
Feb 14, 2022
Next filing
May 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Stock Option (Right to Buy) Award $0 +98.3 +0.1% $0.00 98.3K Jun 15, 2021 Common Stock 98.3K $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option award will vest ratably quarterly to the end of the year.